Ciprofol Matches Propofol for Extubation Time in Pediatric Laparoscopic TIVA
This small single-center trial offers the first randomized pediatric laparoscopic data for ciprofol as the primary total intravenous anesthesia (TIVA) agent, with unusually useful weight-based dosing data for pediatric pharmacists.
📅 Journal publication: 2026(online Nov 8, 2026)·Last updated: Nov 17, 2026
Ciprofol shows promise as an alternative to propofol for pediatric anesthesia.
This study investigates ciprofol as an alternative to propofol for pediatric anesthesia, focusing on safety and extubation time. Ciprofol was non-inferior to propofol with shorter extubation time (17.3 vs 20.1 minutes), and comparable safety profiles. While ciprofol shows promise as a non-inferior alternative to propofol in children, further studies are needed to establish safety and efficacy completely. Ciprofol may be a viable alternative to propofol for pediatric anesthesia, pending further research.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Xu L, Pan R, Dai X, Xu A
Citation:Xu L, Pan R, Dai X, et al. Ciprofol-Based Total Intravenous Anesthesia During Pediatric Laparoscopic Surgery: A Double-Blind, Randomized Controlled, Non-Inferiority Clinical Trial. Drug design, development and therapy. 2026;20:657125. doi:10.2147/DDDT.S657125